Game Over: c*ncer cover art

Game Over: c*ncer

Game Over: c*ncer

Written by: Hi Hello Labs Network
Listen for free

About this listen

Through poignant interviews with pediatric cancer survivors, families, medical professionals, and advocates, Game Over: c*ncer sheds light on the realities of childhood cancer. Each episode explores the efforts and advocacy taking place to find more solutions and make changes for this fatal disease. Hope exhibited by these young warriors and their loved ones is also crucial to our message. From discussing the latest research advancements to sharing personal stories of triumph and loss, the show aims to spark meaningful conversations, foster community support, and drive action toward a world free of childhood cancer. Join us in amplifying these voices, raising awareness, and standing in solidarity with these tiny champs and their families.Copyright Hi Hello Labs Network Economics Management Management & Leadership
Episodes
  • 49. New Treatment Hope for Rare Childhood Leukemia
    Apr 28 2026
    What does it really take to develop new treatments for pediatric cancer?

    In this episode of Game Over: c*ncer, we sit down with Dr. Elliot Stieglitz, a leading pediatric hematologist-oncologist and researcher at UCSF, to break down the reality behind pediatric cancer research, clinical trials, and breakthrough treatments for rare diseases like juvenile myelomonocytic leukemia (JMML).



    JMML is a rare and aggressive form of childhood leukemia affecting just 50–100 children per year in the United States, yet it presents some of the biggest challenges in diagnosis and treatment. Historically, survival rates have been low, and treatment options have been limited.Dr. Stieglitz shares how his groundbreaking research into RAS gene mutations and DNA profiling has:
    • Revolutionized how JMML is diagnosed
    • Enabled faster, more accurate testing worldwide
    • Helped doctors predict which patients need aggressive treatment
    • Opened the door to targeted therapies and clinical trials
    We also dive into the reality of medical research timelines, why innovation takes years, and how nonprofit funding plays a critical role in bringing life-saving treatments to children.If you’ve ever wondered how pediatric cancer breakthroughs actually happen—or what it takes to move from research to real-world impact—this episode is for you.



    ----------------------------------
    Connect with Dana: https://www.linkedin.com/in/danaknichols/
    Connect with Val: https://www.linkedin.com/in/valerie-solomon/

    Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/

    ----------------------------------
    Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/








    Show More Show Less
    32 mins
  • 48. The Hidden Work Behind Fundraising for Pediatric Cancer Research
    Apr 14 2026
    What does it really take to run a nonprofit and fund life-saving pediatric cancer research?

    In this episode of Game Over: c*ncer, we explore the unseen labor behind nonprofit organizations and the behind-the-scenes roles that make fundraising, donor relationships, and events possible.

    Val Solomon and Dana Nichols from Cannonball Kids’ cancer Foundation sit down with Development Assistant Amy Robertson to talk about:
    • The hidden work behind nonprofit events like runDisney
    • How donor stewardship actually works
    • Why administrative and operational roles are critical to impact
    • The emotional reality of working in pediatric cancer advocacy
    • The truth about funding in pediatric cancer research
    Amy shares her journey from mental health and social work into nonprofit development, offering a powerful perspective on how impact happens at every level of an organization.If you’ve ever attended a fundraising event, donated to a cause, or wondered how nonprofits operate behind the scenes, this episode will change how you see it.
    ----------------------------------
    Connect with Dana: https://www.linkedin.com/in/danaknichols/
    Connect with Val: https://www.linkedin.com/in/valerie-solomon/

    Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/

    ----------------------------------
    Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

    Show More Show Less
    28 mins
  • 47. How Poverty Impacts Childhood Cancer Survival | Dr. Kira Bona
    Mar 31 2026
    In this powerful episode of Game Over: c*ncer, hosts Dana and Val sit down with Dr. Kira Bona, pediatric oncologist at Dana-Farber/Boston Children’s Hospital and associate professor at Harvard Medical School, to explore a critical but often overlooked issue in pediatric cancer care: access and health equity.

    Dr. Bona shares groundbreaking research revealing that one in three children diagnosed with cancer lives in a household facing poverty-related challenges, such as food insecurity, housing instability, or lack of transportation. Even when children receive treatment at top hospitals and participate in clinical trials, these social factors can still impact survival outcomes.

    Together, they unpack how social determinants of health influence treatment success, why traditional support systems may not be enough, and what researchers are doing to create health equity interventions that improve outcomes for children and families facing financial hardship.

    This conversation highlights the intersection of oncology and public health, offering hope for a future where every child fighting cancer has an equal chance to survive and thrive.

    Support the Ignite Consortium: https://igniteconsortium.org
    ----------------------------------
    Connect with Dana: https://www.linkedin.com/in/danaknichols/
    Connect with Val: https://www.linkedin.com/in/valerie-solomon/

    Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/

    ----------------------------------
    Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/











    Show More Show Less
    43 mins
No reviews yet